Gracell Biotechnologies Inc reports results for the quarter ended in June - Earnings Summary

Gracell Biotechnologies

17/08/2021 12:47

* Gracell Biotechnologies Inc  GRCL.OQ  reported a quarterly
adjusted loss of 20 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 12 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Gracell Biotechnologies Inc's reported EPS for the quarter was
a loss of 20 cents​.
* The mean earnings estimate of analysts had risen by about 5.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Gracell Biotechnologies Inc shares had fallen by 8.2% this
quarter.
* The company reported a quarterly loss of $14.9 million.
* Wall Street's median 12-month price target for Gracell
Biotechnologies Inc is $33.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 17 at 11:47 a.m.  ​All
figures in US dollars unless otherwise stated